巨化股份(600160.SH):控股股東擬參與轉融通證券出借業務
格隆匯3月15日丨巨化股份(600160.SH)公佈,公司於2021年3月15日收到控股股東巨化集團《關於參與轉融通證券出借業務的吿知函》。近期,巨化集團擬參與轉融通證券出借業務,將其持有的不超過2699.74萬股公司無限售條件流通股,出借給中國證券金融股份有限公司。
截至該公吿發布之日,巨化集團持有公司無限售條件流通股共約14.2278億股,佔公司總股本的52.70%。其中,用於參與轉融通證券出借業務的股份不超過2699.74萬股,佔其所持公司股份總數的1.90%,佔公司總股本的1.00%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.